# Jeuveau

Type: Product

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/jeuveau
Canonical HTML page: https://getfinancebrief.com/entity/jeuveau

## Timeline

- **2026-03-19**: Insider Sale — CMO Rui Avelar sells 29,996 shares of EOLS stock.
- **2026-03-16**: Revenue Targets Raised — Management increases 2028 revenue goals citing market stabilization.
- **2026-03-13**: SEC Filing Update — Company files notice regarding changes or departures in director/officer roles.
- **2026-03-04**: Q4 Earnings Beat — Evolus reports record results and triggers a significant stock rally.

## Recent coverage (1 stories)

### Evolus Insider Rui Avelar Sells Shares Following Record Stock Rally
2026-03-19 15:47:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Evolus Chief Medical Officer Rui Avelar sold 29,996 shares of EOLS stock on March 19, 2026, following a period of significant price appreciation. The transaction occurs as the aesthetics company raises its long-term revenue targets and reports stabilizing trends in the neurotoxin market.
Full story: https://getfinancebrief.com/story/evolus-insider-selling-rui-avelar-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.